(Q43890461)

English

Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections

scientific article published in February 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

Kurt G Naber

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Orlin Savov

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hans C Salmen

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

95-103

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Management of bacterial urinary tract infections in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal ultrasonographic correlates of acute pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam: a critical review of the evolving clinical literature

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility survey of piperacillin alone and in the presence of tazobactam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam in the treatment of polymicrobial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam in complicated urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials of antibacterial agents: a practical guide to design and analysis. Statisticians in the Pharmaceutical Industry Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900481-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(01)00481-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43890461&oldid=2104180742"